Simulations Plus, Inc. hosted Jeremy Jones hosting the ADMETPredictor v14 webinar on September 16 at 11 AM EDT.
Public source
Publisher name
Public post
Bottom Line: AI makes predictions. Mechanistic modeling turns those predictions into decisions. ✅ AI/ML predicts properties quickly → PBPK puts those properties into hum…
Company
Simulations Plus, Inc.
Where are you in the drug development process? Save resources & get to market faster with our solutions!
- Industry
- Software Development
- Location
- Durham, US
- Company size
- 201–500 employees
About Simulations Plus, Inc.
Simulations Plus is a leading provider of modeling and simulation software and consulting services supporting drug discovery, development research, and regulatory submissions. We offer solutions that bridge artificial intelligence (AI) and machine learning (ML), physiologically based pharmacokinetics, quantitative systems pharmacology/toxicology, and population PK/PD modeling approaches. Our technology is licensed and applied by major pharmaceutical, biotechnology, chemical, and consumer goods companies, and regulatory agencies worldwide. For more information visit us at www.simulations-plus.com
See moreLatest activity
Latest activity from Simulations Plus, Inc.
8 signals
Presence & Recognition
Simulations Plus, Inc. experts Lynzie Worth and Jenna Rouse will be at DPHARM 2026
Presence & Recognition
Simulations Plus, Inc. hosted the workshop titled Biopharma AI Operating Platform and in silico Early-Stage ADME/PK/PD Modeling for Beginners: Introduction to Real-World Application Cases at the Korea Chapter of the Pharmaceutical & BioScience Society International (Korea-PBSS)
Research & Knowledge
Simulations Plus, Inc. published a blog post by Dr. Jeremy Jones discussing where mechanistic modeling and AI are intersecting in the discovery space.
Discover more
Similar signals
Similar public activity from other companies.
Presence & Recognition
Medidata Solutions
Medidata Solutions is hosting an upcoming webinar on 8th September 5pm CET featuring Human Virtual Twin Director Steve Levine and partners to share how the company is powering in silico clinical trials and achieving up to 1,000× acceleration in medical device innovation.
Presence & Recognition
BenchSci
BenchSci is hosting a webinar titled Sean Holloran, PhD, running a real drug safety investigation from start to finish using FDA adverse event data, drug interaction risk, and peer-reviewed literature.
Presence & Recognition
OpenADMET
OpenADMET hosted a final webinar in the PXR challenge seminar series featuring the winners of the activity track.
Presence & Recognition
Lhasa Limited
Lhasa Limited is hosting a webinar on 29 September featuring Lucía Toscano Bayona, Dr Maria Celeste del Fueyo, PhD del Fueyo, and Oscar Cortes-Ledezma from Waters Corporation to discuss nitrosamine risk management.
Presence & Recognition
SciNote - Lab Management System